Filing Details
- Accession Number:
- 0001209191-21-057461
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-23 17:17:49
- Reporting Period:
- 2021-09-21
- Accepted Time:
- 2021-09-23 17:17:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1539029 | Clearside Biomedical Inc. | CLSD | Pharmaceutical Preparations (2834) | 452437375 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1815426 | Thomas Ciulla | C/O Clearside Biomedical, Inc. 900 North Point Parkway, Suite 200 Alpharetta GA 30005 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-09-21 | 2,560 | $6.40 | 255,560 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.
- Includes 4,998 shares acquired under the Issuer's employee stock purchase plan on June 30, 2021.
Billionaire Hedge Funds
